Abstract:Five novel ruthenium(II) complexes, [Ru(dtzp)(dppt)](2+) (1), [Ru(dtzp)(pti)](2+) (2), [Ru(dtzp)(ptn)](2+) (3), [Ru(dtzp)(pta)](2+) (4) and [Ru(dtzp)(ptp)](2+) (5) (where dtzp = 2,6-di(thiazol-2-yl)pyridine, dppt = 3-(1,10-phenanthroline-2-yl)-5,6-diphenyl-as-triazine), pti = 3-(1,10-phenanthroline-2-yl)-as-triazino-[5,6-f]isatin, ptn = 3-(1,10-phenanthroline-2-yl)-as-triazino[5,6-f]naphthalene, pta = 3-(1,10-phenanthroline-2-yl)-as-triazino[5,6-f]acenaphthylene, and ptp = 3-(1,10-phenanthroline-2-yl)-as-triazino[5,6-f]-phenanthrene), were synthesised and characterised. The structures of complexes 3-5 were determined by X-ray diffraction. The DNA binding behaviours of the complexes were studied by spectroscopic and viscosity measurements. The results suggested that the Ru(II) complexes, except for complex 1, bind to DNA in an intercalative mode. Topoisomerase inhibition and DNA strand passage assay confirmed that Ru(II) complexes 3, 4, and 5 acted as efficient dual inhibitors of topoisomerases I and IIα. In vitro cytotoxicity assays indicated that these complexes exhibited anticancer activity against various cancer cell lines. Ruthenium(ii) complexes were confirmed to preferentially accumulate in the nucleus of cancer cells and induced DNA damage. Flow cytometric analysis and AO/EB staining assays indicated that these complexes induced cell apoptosis. With the loss of the mitochondrial membrane potential, the Ru(ii) complexes induce apoptosis via the mitochondrial pathway.

Ruthenium (II) complexes containing a new asymmetric ligand: DNA interaction, photocleavage and topoisomerase i inhibition

DNA-binding and Photocleavage Studies of Ruthenium(ii) Complexes Containing Asymmetric Intercalative Ligand.

DNA-binding, photocleavage studies of ruthenium(II) complexes with 2-(2-quinolinyl) imidazo[4,5-f][1,10]phenanthroline.

Ruthenium(II) Complexes Containing Asymmetric 2-(Pyrazin-2-yl)naphthoimidazole: Syntheses, Characterization, DNA-binding and Photocleavage Studies

Ruthenium(Ii) Complexes Containing Asymmetric Ligands: Synthesis, Characterization, Crystal Structure and Dna-Binding

Synthesis, Characterization, and DNA Binding Studies of Ruthenium(II) Complexes with 2-Pyridyl-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-6,11-dione

Synthesis, DNA-binding and Topoisomerase Inhibitory Activity of Ruthenium(ii) Polypyridyl Complexes

Synthesis, Characterization and DNA-binding Studies of Ruthenium(ii) Mixed-Ligand Complexes Containing Dipyrido[1,2,5]oxadiazolo[3,4-B]quinoxaline.

Synthesis, DNA-binding and photocleavage studies of ruthenium(II) complex with 2-(3'-phenoxyphenyl)imidazo[4,5-f][1,10]phenanthroline.

Ruthenium(II) mixed-ligand complexes containing 2-(6-methyl-3-chromonyl)imidazo[4,5-f][1,10]-phenanthroline: Synthesis, DNA-binding and photocleavage studies

Dual Inhibition of Topoisomerases I and IIα by Ruthenium(ii) Complexes Containing Asymmetric Tridentate Ligands

Synthesis, Dna-Binding and Photocleavage Studies of Ruthenium Complexes [ru(bpy)(2)(mitatp)](2+) and [Ru(bpy)(2)(nitatp)](2+)

A Ruthenium(ii) Arene Complex Showing Emission Enhancement and Photocleavage Activity Towards DNA from Singlet and Triplet Excited States Respectively.

Ruthenium(II) Terpyridyl Complexes Exhibiting DNA Photocleavage: the Role of the Substituent on Monodentate Ligand.

Synthesis, DNA-binding and photocleavage studies of the ruthenium(II) complexes [Ru(phen)2(ppd)]2+ and [Ru(phen)(ppd) 2]2+ (ppd = pteridino[6,7-f] [1,10]phenanthroline-11, 13(10H,12H)-dione, phen = 1,10-phenanthroline)

Synthesis, DNA-binding, DNA-photocleavage and antioxidant activity of ruthenium(II) complex containing triazine ring ligand: [Ru(dmb) 2(pdta)](ClO4)2

Synthesis, DNA-binding and Photocleavage Studies of Ruthenium(ii) Complexes [ru(btz) 3 ] 2+ and [ru(btz)(dppz) 2 ] 2+

Interaction of Polypyridyl Ruthenium (II) Complex Containing Asymmetric Ligand with DNA

Ruthenium(ii) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase.

Synthesis, GC selective DNA binding and topoisomerase II inhibition activities of ruthenium(II) polypyridyl complex containing 11-aminopteridino[6,7-f][1,10]phenanthrolin-13(12H)-one.

Mono- and Bi-Nuclear Ruthenium(ii) Complexes Containing a New Asymmetric Ligand 3-(Pyrazin-2-yl)-as-triazino[5,6-f ]1,10-Phenanthroline: Synthesis, Characterization and DNA-binding Properties